Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -0.96% | -7.23% | -55.81% |
Apr. 03 | Stifel Cuts Price Target on Verve Therapeutics to $40 From $56, Maintains Buy Rating | MT |
Apr. 02 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 13.01M | Sales 2025 * | 10.02M | Capitalization | 517M |
---|---|---|---|---|---|
Net income 2024 * | -226M | Net income 2025 * | -254M | EV / Sales 2024 * | 5.92 x |
Net cash position 2024 * | 440M | Net cash position 2025 * | 204M | EV / Sales 2025 * | 31.2 x |
P/E ratio 2024 * |
-2.1
x | P/E ratio 2025 * |
-2.02
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.35% |
Latest transcript on Verve Therapeutics, Inc.
1 day | -0.96% | ||
1 week | -7.23% | ||
Current month | -53.61% | ||
1 month | -53.61% | ||
3 months | -46.62% | ||
6 months | -30.32% | ||
Current year | -55.81% |
Managers | Title | Age | Since |
---|---|---|---|
Sekar Kathiresan
FOU | Founder | 52 | 17-12-31 |
Allison Dorval
DFI | Director of Finance/CFO | 48 | 21-11-28 |
Andrew Ashe
PSD | President | 57 | 18-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Burt Adelman
FOU | Founder | 71 | 17-12-31 |
Lonnel Coats
BRD | Director/Board Member | 58 | 22-08-07 |
Michael MacLean
BRD | Director/Board Member | 58 | 21-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.13% | 2 M€ | -25.75% | ||
3.54% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.16 | -0.96% | 791,566 |
24-04-25 | 6.22 | -5.47% | 1,221,227 |
24-04-24 | 6.58 | -4.36% | 1,003,979 |
24-04-23 | 6.88 | -0.43% | 965,009 |
24-04-22 | 6.91 | +4.07% | 909,065 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.81% | 517M | |
+1.51% | 42.75B | |
+47.98% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VERV Stock